193 related articles for article (PubMed ID: 25414244)
1. Severity grading of chronic obstructive pulmonary disease: the confounding effect of phenotype and thoracic gas compression.
Pellegrino R; Crimi E; Gobbi A; Torchio R; Antonelli A; Gulotta C; Baroffio M; Papa GF; Dellacà R; Brusasco V
J Appl Physiol (1985); 2015 Apr; 118(7):796-802. PubMed ID: 25414244
[TBL] [Abstract][Full Text] [Related]
2. The objective evaluation of obstructive pulmonary diseases with spirometry.
Ozkaya S; Dirican A; Tuna T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
[TBL] [Abstract][Full Text] [Related]
3. Dependence of bronchoconstrictor and bronchodilator responses on thoracic gas compression volume.
Pellegrino R; Antonelli A; Crimi E; Gulotta C; Torchio R; Dutto L; Pedersen OF; Brusasco V
Respirology; 2014 Oct; 19(7):1040-5. PubMed ID: 25039769
[TBL] [Abstract][Full Text] [Related]
4. Altered thoracic gas compression contributes to improvement in spirometry with lung volume reduction surgery.
Sharafkhaneh A; Goodnight-White S; Officer TM; Rodarte JR; Boriek AM
Thorax; 2005 Apr; 60(4):288-92. PubMed ID: 15790983
[TBL] [Abstract][Full Text] [Related]
5. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
6. Is FEV1 determined in a plethysmograph a better indication of obstructive lung disease than FEV1 determined by a spirometer?
Pedersen OF
J Appl Physiol (1985); 2015 Apr; 118(7):795. PubMed ID: 25549766
[No Abstract] [Full Text] [Related]
7. [Pulmonary function tests in chronic obstructive pulmonary disease].
Weitzenblum E; Canuet M; Kessler R; Chaouat A
Presse Med; 2009 Mar; 38(3):421-31. PubMed ID: 19171454
[TBL] [Abstract][Full Text] [Related]
8. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
Celli BR; Cote CG; Marin JM; Casanova C; Montes de Oca M; Mendez RA; Pinto Plata V; Cabral HJ
N Engl J Med; 2004 Mar; 350(10):1005-12. PubMed ID: 14999112
[TBL] [Abstract][Full Text] [Related]
9. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
10. Tidal expiratory flow limitation at rest as a functional marker of pulmonary emphysema in moderate-to-severe COPD.
Chiari S; Bassini S; Braghini A; Corda L; Boni E; Tantucci C
COPD; 2014 Feb; 11(1):33-8. PubMed ID: 24102405
[TBL] [Abstract][Full Text] [Related]
11. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
Majumdar S; Sen S; Mandal SK
J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
[TBL] [Abstract][Full Text] [Related]
12. Surgical therapy for chronic obstructive pulmonary disease.
Martinez FJ; Chang A
Semin Respir Crit Care Med; 2005 Apr; 26(2):167-91. PubMed ID: 16088435
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and examination for COPD. Pulmonary function tests].
Kubota M
Nihon Rinsho; 2016 May; 74(5):763-7. PubMed ID: 27254943
[TBL] [Abstract][Full Text] [Related]
14. Predicting the risk of exacerbation in patients with chronic obstructive pulmonary disease using home telehealth measurement data.
Mohktar MS; Redmond SJ; Antoniades NC; Rochford PD; Pretto JJ; Basilakis J; Lovell NH; McDonald CF
Artif Intell Med; 2015 Jan; 63(1):51-9. PubMed ID: 25704112
[TBL] [Abstract][Full Text] [Related]
15. Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease.
Kirby M; Pike D; Coxson HO; McCormack DG; Parraga G
Radiology; 2014 Dec; 273(3):887-96. PubMed ID: 24960283
[TBL] [Abstract][Full Text] [Related]
16. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
17. Lung-volume reduction surgery for pulmonary emphysema: Improvement in body mass index, airflow obstruction, dyspnea, and exercise capacity index after 1 year.
Lederer DJ; Thomashow BM; Ginsburg ME; Austin JH; Bartels MN; Yip CK; Jellen PA; Brogan FL; Kawut SM; Maxfield RA; DiMango AM; Simonelli PF; Gorenstein LA; Pearson GD; Sonett JR
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1434-8. PubMed ID: 17532935
[TBL] [Abstract][Full Text] [Related]
18. [Lung function test for COPD].
Itabashi S
Nihon Rinsho; 2003 Dec; 61(12):2150-7. PubMed ID: 14674325
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal assessment in COPD patients: multidimensional variability and outcomes.
Casanova C; Aguirre-Jaíme A; de Torres JP; Pinto-Plata V; Baz R; Marin JM; Divo M; Cordoba E; Basaldua S; Cote C; Celli BR
Eur Respir J; 2014 Mar; 43(3):745-53. PubMed ID: 24072210
[TBL] [Abstract][Full Text] [Related]
20. Predominant emphysema phenotype in chronic obstructive pulmonary.
Boschetto P; Miniati M; Miotto D; Braccioni F; De Rosa E; Bononi I; Papi A; Saetta M; Fabbri LM; Mapp CE
Eur Respir J; 2003 Mar; 21(3):450-4. PubMed ID: 12662000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
